All Type of News
MSD & GSK only brought dishonor on NIP over their cervical cancer vaccines
The pharmaceutical companies which delayed the enforcement day to raise profits on the NIP project with cervical cancer vaccines did not earn substance, but only brought dishonor.
This is because the unit prices bid ...
Remsima acquires IBD indication in Canada, accelerating expansion into NA market
Celltrion announced it acquired an addition indication of inflammatory bowel disease(IBD) for its autoimmune disease therapy, antibody biosimilar ‘Remsima(local name: Inflectra)’ from the Health Canada on June 10(loca...
Why did pharmaceutical association postpone secret voting?
Since the rebate situation has been developed, the ‘secret voting’ got also delayed. Despite a part of the industry’s opposition, the secret voting which has been conducted for 3 times so far has been evaluated that i...
Humira’s PMS ends on August, triggering biosimilar development competition
The domestic PMS(post marketing surveillance) of Humira(adalimumab, Abbvie), a rheumatoid arthritis treatment having the globally KRW 16 trillion sales market, will end this August.
Since the development of Humira b...
Why did domestic companies join in ADA to announce their new antidiabetics?
With study results of antidiabetics that are being developed with foreign pharmaceutical companies, domestic companies started to knock the door of the American Diabetes Association(ADA).
Domestic new drugs represent...
12 property insurance companies face lawsuits under suspicion of ‘unjust collision’
Property insurance companies which excluded varicose vein laser and high-frequency surgeries from the object to pay insurance benefits will face lawsuits under the suspicion of collision by changing terms not to give ...
Government’s attachment to ‘biopharmaceutical’ discouraging pharmaceutical field
As the government tightening the fostering policy for new growth engines, the pharmaceutical industry raise a voice that the industry cannot be dualistically categorized into pharmaceutical and biopharmaceutical.
T...
Government confirmed to push forwards bills for telemedicine dispensers as noticed
The government finalized plans to turn in a legislation bill to allow to sell OTC drugs through video telemedicine dispensers to the National Assembly. The due is by October, as well as the legislation bill to adopt d...
Physicians’ opposition even with extension of indications on ‘Daklinza’
Medical personnel have expressed opposition to the fact that the indication for genotype 2 was excluded from ‘Daklinza(generic name: daclatasvir)’ during the process of extending indications.
Recently, the Ministry o...
Will Hanmi Pharm start to develop modified drug of ‘Evista’?Hanmi Pharm is about to jump in the development of incrementally modified drug of Evista(generic name: raloxifene), an osteoporosis therapy.
Hanmi Pharm was confirmed to file a...
|
